Results 191 to 200 of about 190,239 (217)

Quantifying structural selection bias in observational cohort data: a ponderation analysis of age - specific incidence rates to inform vaccine safety verification. [PDF]

Front Pharmacol
Roccetti M.
europepmc   +1 more source

mRNA COVID-19 vaccine safety among children and adolescents: a Canadian National Vaccine Safety Network cohort study. [PDF]

Lancet Reg Health Am
Soe P, Vanderkooi OG, Sadarangani M, Naus M, Muller MP, Kellner JD, Top KA, Wong H, Isenor JE, Marty K, Shulha HP, De Serres G, Valiquette L, McGeer A, Bettinger JA.   +14 more
europepmc   +1 more source

Implementation and Results of Active Vaccine Safety Monitoring During the COVID-19 Pandemic in the UK: A Regulatory Perspective. [PDF]

Drug Saf
Wong J, Donegan K, Harrison K, Jan T, Cave A, Tregunno P.   +5 more
europepmc   +1 more source

Correction to "Eosinophils and COVID-19: Insights into immune complexity and vaccine safety". [PDF]

Clin Transl Allergy
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Clinician communication strategies associated with increased uptake of the human papillomavirus (HPV) vaccine: A systematic review

Ca-A Cancer Journal for Clinicians, 2022
Joey Nicholson, Kyle Ferguson, Gwendolyn P Quinn   +2 more
exaly  

Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems

Vaccine, 2022
Allison L. Naleway, Michael L Jackson, Lina S Sy   +2 more
exaly  

American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors†

Ca-A Cancer Journal for Clinicians, 2007
Philip E. Castle, Mark Einstein
exaly